STOCK TITAN

Cushman & Wakefield Ltd Form 4 Filings

CWK NYSE

Every Form 4 that Cushman & Wakefield Ltd (CWK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CWK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CWK filings page.

Rhea-AI Summary

Sayed Laurida, an officer and Chief Accounting Officer of Cushman & Wakefield Ltd. (CWK), reported a sale of 16,000 Common Shares on August 13, 2026, at $13.88 per share in an open-market or private transaction. Following this sale, Laurida directly holds 5,461 Common Shares. The filing indicates the transaction was not made pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Timothy H. Wennes converted 11,873 previously awarded restricted stock units into 11,873 common shares on August 1, 2026, without paying consideration, upon vesting under the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. He now directly holds 11,873 common shares and no RSUs from this grant.

Rhea-AI Summary

Susan Daimler, a director of Cushman & Wakefield Ltd., converted 11,873 previously granted restricted stock units into the same number of common shares on August 1, 2026, without paying consideration, under the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. The RSUs were granted on August 1, 2025 and fully vested and settled on that date, leaving her with 11,873 common shares held directly.

Rhea-AI Summary

Cushman & Wakefield Ltd. Chief Executive Officer Michelle Mackay reported equity compensation activity involving restricted stock units that vested into common shares. On July 1, 2026, 24,960 RSUs converted into the same number of common shares under the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan. To satisfy tax obligations related to these and other awards, a total of 87,509 common shares were disposed of through tax-withholding transactions at $13.84 per share, rather than through open-market sales.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Andrew R. McDonald reported compensation-related share movements. Previously awarded restricted stock units converted into 10,697 common shares at no cost under the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan. To cover tax obligations, 34,506 common shares were withheld at about $13.84 per share, and McDonald held 455,623 common shares directly after the reported transactions.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Noelle J. Perkins reported compensation-related equity activity involving restricted stock units and common shares. On July 1, 2026, previously awarded RSUs converted into common shares without cash payment under the company’s Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan. On the same date, the company withheld shares valued at $13.84 per share to cover tax obligations tied to vesting and performance-based RSUs, so these dispositions were for tax payments rather than open-market sales.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Nathaniel Robinson reported an open-market sale of Common Shares. On June 4, 2026, he sold 24,828 Common Shares at $13.25 per share. After this transaction, he directly holds 70,876 Common Shares, indicating he retains a substantial equity stake in the company.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Michelle Felman reported bona fide gifts of a total of 34,026 Common Shares on June 1, 2026. The transactions reflect gift transfers rather than any open-market buying or selling.

One 17,013-share gift involved shares previously held directly, leaving her with no direct holdings. Another 17,013-share gift involved shares associated with family trusts. Following these transactions, she reports 44,857 Common Shares held indirectly through family trusts, over which she has investment control, for the sole benefit of certain immediate family members.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Michelle Felman reported equity compensation activity involving restricted stock units (RSUs). On May 15, 2026, she exercised previously awarded RSUs, converting 17,013 RSUs into the same number of common shares without paying any cash consideration.

On May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle on May 14, 2027, subject to continued board service. Following these transactions, she holds 17,013 common shares directly, 27,844 common shares indirectly through family trusts over which she has investment control, and 14,041 RSUs outstanding.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Billie Ida Williamson reported routine equity compensation movements involving restricted stock units (RSUs) and common shares. On May 15, 2026, previously awarded RSUs converted into 17,013 common shares without any cash payment, under the company’s omnibus non-employee director incentive plan.

Following this conversion, Williamson held 106,005 common shares directly. A day earlier, on May 14, 2026, Williamson received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, if board service continues through that date. The Form 4 shows no open-market purchases or sales, only compensation-related grants and RSU conversions.

Rhea-AI Summary

PLAVIN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.

Cushman & Wakefield Ltd. director Stephen D. Plavin reported a compensation-related grant of 21,841 restricted stock units on May 14, 2026. Each RSU represents one common share and requires no purchase price.

The RSUs vest and settle on May 14, 2027, generally contingent on his continued board service through that date. Following this award, he holds 21,841 RSUs directly, each convertible into an equal number of common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. reported that director Susan Daimler received a grant of 14,041 restricted stock units (RSUs). These RSUs were granted on May 14, 2026 under the company’s 2026 Omnibus Share and Cash Incentive Plan as equity-based board compensation.

The RSUs convert into an equal number of common shares without any cash payment, but they vest and settle on May 14, 2027, generally requiring her continued board service through that date. After this grant, she is reported as holding 14,041 RSUs directly, with no open-market purchases or sales disclosed in this filing.

Rhea-AI Summary

Cushman & Wakefield Ltd. reported that director Timothy H. Wennes received a grant of 14,041 restricted stock units (RSUs). These RSUs were awarded under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan and will convert into an equal number of common shares without any cash payment.

The RSUs were granted on May 14, 2026 and are scheduled to vest and settle on May 14, 2027, generally conditional on his continued board service through that date. Following this grant, Wennes holds 14,041 RSUs directly.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Jodie W. McLean reported compensation-related equity activity. On May 15, 2026, previously awarded restricted stock units (RSUs) for 17,013 shares converted into the same number of common shares without any cash payment, leaving her with 88,836 common shares held directly.

Separately, on May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, subject to her continued board service. These are routine director equity awards and RSU settlements, not open-market share purchases or sales.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Angela Sun reported routine equity compensation activity. On May 15, 2026, previously awarded restricted stock units converted into 17,013 common shares without any cash payment, under the company’s non-employee director incentive plan. The same day, the corresponding 17,013 RSUs were fully settled and reduced to zero. On May 14, 2026, she also received a new grant of 14,041 RSUs that will vest and settle on May 14, 2027, subject to her continued board service. Following these transactions, she directly owns 63,511 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Rajesh Vennam reported equity compensation activity involving restricted stock units (RSUs). On May 15, he converted 17,013 RSUs into the same number of common shares at no cost under the company’s director incentive plan, bringing his direct common share holdings to 35,516 shares.

On May 14, Vennam also received a new award of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, if he continues board service. These are compensation-related grants and conversions rather than open-market buying or selling.

Rhea-AI Summary

Cushman & Wakefield Ltd. director Jennifer J. McPeek reported routine equity compensation activity. On May 15, 2026, previously awarded restricted stock units (RSUs) covering 17,013 common shares converted into the same number of common shares without any cash changing hands, under the company’s non‑employee director incentive plan.

Separately, on May 14, 2026, she received a new grant of 14,041 RSUs, which are scheduled to vest and settle on May 14, 2027, generally conditioned on her continued board service. Following these transactions, she directly holds 35,516 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Nathaniel Robinson reported an open-market sale of 10,000 Common Shares on May 12, 2026 at a weighted average price of $13.52 per share. According to the filing, the trades occurred in a price range of $13.50 to $13.53. After these transactions, Robinson directly holds 95,704 Common Shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Nathaniel Robinson reported an open-market sale of 10,000 common shares at $13.50 per share. After this transaction, he directly owns 105,704 common shares. This filing reflects a single reported sale transaction.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Nathaniel Robinson reported multiple equity award transactions. He received a grant of 36,101 restricted stock units (RSUs) on February 26, 2026, which will vest in three equal annual installments if he remains employed.

On February 27, 2026, 14,005 RSUs previously awarded under the company’s Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan automatically converted into 14,005 common shares without any cash payment. To cover tax obligations, 3,957 common shares were disposed of at $13.41 per share, leaving him with 115,704 common shares held directly.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Andrew R. McDonald reported equity compensation activity and related tax withholding. He received a grant of 138,989 restricted stock units (RSUs) on February 26, 2026 under the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan, which will vest in three substantially equal annual installments if he remains employed.

On February 27, 2026, 53,921 RSUs previously awarded converted into the same number of common shares without cash payment, and 27,436 common shares were disposed of at $13.41 per share to satisfy tax obligations. Following these transactions, he directly held 450,369 common shares and 138,989 RSUs.

Rhea-AI Summary

Cushman & Wakefield Ltd. reported equity compensation and related share movements for Chief Executive Officer Michelle MacKay. On February 26, 2026, she was granted 370,036 restricted stock units (RSUs) that will vest and settle in three substantially equal annual installments, conditioned on continued employment. On February 27, 2026, 101,540 previously awarded RSUs were converted into an equal number of common shares at no cash cost under the company’s omnibus incentive plan. To cover tax obligations tied to this vesting, 56,152 common shares were disposed of at $13.41 per share, leaving her with 415,104 common shares held directly.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Neil O. Johnston reported equity compensation and related share movements. On February 26, 2026, he received a grant of 79,423 restricted stock units (RSUs) under the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan, scheduled to vest in three substantially equal annual installments, subject to continued employment. On February 27, 2026, 30,812 RSUs converted into an equal number of common shares at no cost, and 13,724 common shares were disposed of at $13.41 per share to cover tax obligations. After these transactions, he directly held 317,017 common shares and 79,423 RSUs.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Noelle J. Perkins reported equity compensation activity involving restricted stock units (RSUs) and common shares. On February 26, 2026, she was granted 39,711 RSUs, which will vest and settle in three equal annual installments, subject to continued employment.

On February 27, 2026, 15,406 RSUs previously awarded under the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan converted into 15,406 common shares without cash payment, and 4,514 common shares were withheld at $13.41 per share to satisfy tax obligations.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Sayed Laurida reported equity compensation activity and related share withholding. On February 26, 2026, Laurida received 13,538 restricted stock units (RSUs), which are scheduled to vest and settle in three substantially equal annual installments, subject to continued employment.

On February 27, 2026, 5,602 previously awarded RSUs were converted into an equal number of common shares without payment of consideration under the company’s Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan. On the same date, 1,655 common shares at $13.41 per share were withheld to cover tax obligations, leaving Laurida with 21,461 common shares held directly after these transactions.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Neil O. Johnston reported equity award activity in company common shares. On the reported date, he acquired 146,337 common shares at $0.0000 per share through the exercise or conversion of a derivative award, reflecting vesting of performance-based restricted stock units for the 2023–2025 performance period under the company’s incentive plan. In a related tax-withholding disposition, 58,141 common shares were delivered at $13.76 per share to satisfy tax obligations tied to this vesting, a non‑open‑market transaction. Following these transactions, Johnston directly owned 299,929 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. Chief Executive Officer Michelle Mackay reported equity award activity in common shares. On February 25, 2026, she acquired 202,877 common shares at $0.00 per share through the exercise or conversion of a derivative security tied to performance-based restricted stock units for the 2023 to 2025 performance period. On the same date, she disposed of 112,191 common shares at $13.76 per share to cover exercise price or tax liabilities. Following these transactions, she directly owned 369,716 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. executive Andrew R. McDonald reported equity compensation activity involving the company’s common shares. On February 25, 2026, he acquired 186,249 common shares at $0.00 per share through the exercise or conversion of a derivative security, reflecting the vesting of performance-based restricted stock units earned for the 2023–2025 performance period under the company’s incentive plan. On the same date, he disposed of 94,764 common shares at $13.76 per share in a tax-withholding transaction to satisfy exercise price or tax liabilities by delivering shares. After these transactions, McDonald directly held 423,884 common shares of Cushman & Wakefield Ltd.

Rhea-AI Summary

Cushman & Wakefield Ltd. executive Nathaniel Robinson reported equity compensation activity involving the company’s common shares. On February 25, 2026, he acquired 53,213 common shares at $0.00 per share through the exercise or conversion of a derivative security, reflecting the vesting of performance-based restricted stock units tied to 2023–2025 performance targets under the company’s omnibus incentive plan.

On the same date, 12,958 common shares were disposed of at $13.76 per share to cover the exercise price or tax withholding obligations. After these transactions, Robinson directly owned 105,656 common shares of Cushman & Wakefield.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Andrew R. McDonald reported the vesting of restricted stock units and related tax withholding. On February 23, 34,878 restricted stock units were converted into an equal number of common shares at no cost under the company’s incentive plan. On the same date, 17,937 common shares at a price of $12.93 per share were surrendered to cover tax liabilities associated with the RSU vesting, a tax-withholding disposition rather than an open-market sale. Following these transactions, McDonald directly owned 332,399 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Neil O. Johnston reported equity award activity tied to previously granted restricted stock units (RSUs). On February 23, 2026, 27,405 RSUs converted into an equal number of common shares at $0.00 per share under the company’s 2018 Omnibus Management Share and Cash Incentive Plan.

In a related transaction, 8,399 common shares were withheld at $12.93 per share to satisfy tax obligations, a tax-withholding disposition rather than an open-market sale. Following these transactions, Johnston directly owned 211,733 common shares of Cushman & Wakefield.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Nathaniel Robinson converted 9,966 restricted stock units into an equal number of common shares at no cost under the company’s 2018 incentive plan. To cover tax obligations, 2,871 common shares were withheld at $12.93 per share, leaving him with 65,401 directly owned common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. Chief Executive Officer Michelle Mackay converted 37,992 previously awarded restricted stock units into the same number of common shares on February 23, 2026, at no cost, under the company’s 2018 incentive plan. To cover related tax obligations, 21,003 common shares were disposed of at $12.93 per share, leaving her with direct ownership of 279,030 common shares. The RSUs were originally granted on February 23, 2023 and vest in three equal annual installments, contingent on continued employment.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Sayed Laurida reported multiple equity award transactions involving restricted stock units (RSUs) and common shares. On February 22 and 23, 2026, previously granted RSUs converted into 6,661 and 2,492 common shares, respectively, at $0.00 per share, reflecting vesting under the company’s omnibus incentive plan. In connection with these vestings, the company withheld 2,306 and 863 common shares at $13.33 and $12.93 per share to satisfy tax obligations through share delivery rather than cash. After these transactions, Laurida directly owned 17,514 common shares.

Rhea-AI Summary

Cushman & Wakefield Ltd. officer Noelle J. Perkins reported the vesting of previously granted restricted stock units. On February 22, 2026, 14,985 RSUs converted into an equal number of common shares at $0.00 per share under the company's 2018 Omnibus Management Share and Cash Incentive Plan.

As part of the same event, 4,755 common shares were automatically withheld at a price of $13.33 per share to cover tax obligations, leaving Perkins with 63,065 common shares held directly after the transactions. The RSUs were originally granted on February 22, 2024 and vest in three equal annual installments, subject to continued employment.